NCT01294917

Brief Summary

Crossover clinical evaluation three contact lens care regimens used for one month with Acuvue Oasys lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

February 10, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 14, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
10 months until next milestone

Results Posted

Study results publicly available

May 14, 2012

Completed
Last Updated

March 6, 2017

Status Verified

January 1, 2017

Enrollment Period

6 months

First QC Date

February 10, 2011

Results QC Date

February 15, 2012

Last Update Submit

January 20, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Corneal Staining

    Corneal staining will be assessed with sodium fluorescein dye on the ocular surface. The cornea is split into 5 sections, each section is evaluated by staining type, depth, and extent is graded on a 0 to 100 scale with higher scores indicating more staining. The possible total range for the total score per eye is 0 to 50,000 (100x100x100=10,000 per section) with values higher than 1200 being clinically relevant.

    4 weeks

Secondary Outcomes (2)

  • Subjective Lens Wearing Comfort

    4 weeks

  • Dryness

    4 weeks

Study Arms (3)

Investigational MPS

EXPERIMENTAL

AMO Investigational MPS.

Device: Multi-purpose disinfecting solution

Clear Care

ACTIVE COMPARATOR

Peroxide-based lens care regimen.

Device: Clear Care

Opti-Free RepleniSH

ACTIVE COMPARATOR

Multi-purpose disinfecting solution (Alcon).

Device: Opti-Free RepleniSH

Interventions

For the cleaning, rinsing, and storage of soft contact lenses.

Investigational MPS

Peroxide-based regimen for cleaning and disinfecting soft contact lenses.

Clear Care

Multi-purpose disinfecting solution for the cleaning, rinsing and storing of soft contact lenses.

Opti-Free RepleniSH

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Is at least 17 years of age and has full legal capacity to volunteer;
  • Has read and signed an information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Has had an ocular examination in the last two years;
  • Is a current soft lens wearer using either two-week or monthly replacement lenses;
  • Is correctable to a visual acuity of 6/7.5 (20/25) or better (both eyes) with their habitual vision correction (either spectacles or contact lenses);
  • Has normal binocular vision (no strabismus, no amblyopia);
  • Has clear corneas and no active ocular disease;
  • Has a distance contact lens prescription between +8.00 diopters (D) to -12.00 D and a successful fit with the study lenses;
  • Has astigmatism less than or equal to -1.00 D;
  • Agrees to wear the study lenses on a daily wear basis.

You may not qualify if:

  • Has any active ocular disease;
  • Has any clinically significant lid, conjunctival, or corneal abnormalities that may affect a study outcome variable;
  • Has undergone corneal refractive surgery;
  • Has a systemic condition that may affect a study outcome variable;
  • Is using any systemic or topical medications that may affect ocular health;
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  • Is pregnant or lactating;
  • Is participating in any other clinical or research study that may affect a study outcome variable;
  • Currently wears daily disposable lenses or extended wear lenses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Contact Lens Research

Waterloo, Ontario, N2L 3G1, Canada

Location

Results Point of Contact

Title
Clinical Scientist
Organization
Centre for Contact Lens Research

Study Officials

  • Craig Woods, MOptom

    University of Waterloo

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2011

First Posted

February 14, 2011

Study Start

February 1, 2011

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

March 6, 2017

Results First Posted

May 14, 2012

Record last verified: 2017-01

Locations